Therapeutic landscape of advanced HER2-positive breast cancer in 2022
Ruby Gupta, Sachin Gupta, Bana Antonios, Bipin Ghimire, Vishal Jindal, Jaskiran Deol, Suzanna Gaikazian, Marianne Huben, Joseph Anderson, Michael Stender, Ishmael Jaiyesimi
Topics & Concepts
TrastuzumabLapatinibMedicinePertuzumabCapecitabineOncologyTrastuzumab emtansineTaxaneInternal medicineMetastatic breast cancerNeratinibBreast cancerEribulinCancerColorectal cancerHER2/EGFR in Cancer ResearchAdvanced Breast Cancer TherapiesMonoclonal and Polyclonal Antibodies Research